ArticleJournal of ovarian research2026
Quercetin induces ferroptosis in ovarian cancer through regulating HSPB1/Notch1 pathway.
Article in Journal of ovarian research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Ferroptosis Signature Correlates with Ovarian Cancer Prognosis and Chemotherapy Response.International journal of general medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
objectiveFerroptosis, characterized by iron dependency and lipid peroxidation, is essential in tumor development and chemotherapy resistance. Quercetin, a natural flavonoid, exhibits anticancer activity in various tumors. The study aimed to explore whether quercetin suppresses ovarian cancer by inducing ferroptosis, as well as to uncover the associated regulatory mechanisms.
methodsThe impact of quercetin on promoting ferroptosis, affecting cell apoptosis, growth, and lipid peroxidation, was assessed in the human ovarian cancer cell lines A2780 and SKOV3. Cell proliferation was evaluated by CCK-8 and colony formation experiments, whereas apoptosis and lipid peroxidation were measured through flow cytometry and malondialdehyde assays, respectively. Bioinformatics analysis identified potential targets of quercetin-induced ferroptosis, and molecular docking predicted the binding interaction between quercetin and HSPB1. The expression levels of ferroptosis-related genes at the mRNA level were quantified by qRT-PCR, while the protein levels of heat shock protein beta-1 (HSPB1), glutathione peroxidase 4 (GPX4), Notch1, Notch intracellular domain (NICD) and its downstream effectors HEY1 and HES1 were assessed by western blotting. Ferrostatin-1 was co-treated with quercetin to determine the role of ferroptosis in quercetin-mediated anti-proliferative effects. The Notch1 inhibitor tangeretin was used to explore mechanistic pathways. An in vivo study was conducted using a xenograft mouse model.
resultsQuercetin inhibited cell proliferation and colony formation, triggered apoptosis, and promoted ferroptosis in A2780 and SKOV3 cells, marked by GPX4 downregulation and malondialdehyde levels increase. Quercetin decreased HSPB1 expression and was predicted to bind HSPB1. Silencing HSPB1 enhanced quercetin-induced cell death and malondialdehyde accumulation, while its overexpression reversed these effects. HSPB1 regulated Notch1/NICD expression, and Notch1 inhibition amplified ferroptosis. In vivo, quercetin suppressed tumor growth and reduced HSPB1, NICD, and GPX4 levels, and increased 4-hydroxynonenal (4-HNE).
conclusionsThis study demonstrates that quercetin promotes ferroptosis and suppresses ovarian cancer progression through the HSPB1/Notch1 axis, highlighting its potential as an adjuvant in ovarian cancer therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.